GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119

被引：39
|
作者：
Kang, Sang-Uk [1 ]
机构：
[1] Kosin Univ, Dept Life Sci, Pusan, South Korea
来源：
DRUG DISCOVERY TODAY | 2013年 / 18卷 / 23-24期
关键词：
PROTEIN-COUPLED RECEPTOR; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GLUCOKINASE ACTIVATORS; INSULIN-SECRETION; GLYCEMIC CONTROL; DISCOVERY; INHIBITORS; POTENT; ACID; THERAPY;
D O I：
10.1016/j.drudis.2013.09.011
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Ever since its advent as a promising therapeutic target for type 2 diabetes mellitus (T2DM), G-protein-coupled receptor 119 (GPR119) has received much interest from the pharmaceutical industry. This interest peaked in June 2010, when Sanofi-Aventis agreed to pay Metabolex (Cymabay Therapeutics) US$375 million for MBX-2982, which was a representative orally active GPR119 agonist. However, Sanofi-Aventis opted to terminate the deal in May 2011 and another leading GPR119 agonist, G5K1292263, had a loss of efficacy during its clinical trial. In this review, I discuss the pros and cons of GPR119 through a strengths, weaknesses, opportunities, and threats (SWOT) analysis and propose development strategies for the eventual success of a GPR119 agonist development program.
引用
收藏
页码：1309 / 1315
页数：7
相关论文
共 50 条
  • [31] Interrogating the Signaling Mechanisms of GPR119: a Novel Target for Type 2 Diabetes Mellitus (T2DM) and Obesity
    Adhikari, Pramisha
    Sturchler, Emmanuel
    Mcdonald, Patricia
    [J]. DIABETES, 2016, 65 : A448 - A448
  • [32] Clinical implication of a novel G protein-coupled receptor GPR119: GPR119 gene expression in humans
    Odori, Shinji
    Hosoda, Kiminori
    Tomita, Tsutomu
    Fujikura, Junji
    Iwakura, Hiroshi
    Noguchi, Michio
    Mori, Eisaku
    Naito, Masaki
    Kusakabe, Toru
    Ebihara, Ken
    Masuzaki, Hiroaki
    Nakao, Kazuwa
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S361 - S361
  • [33] Design and synthesis of novel and potent GPR119 agonists with a spirocyclic structure
    Harada, Kazuhito
    Mizukami, Jun
    Kadowaki, Sho
    Matsuda, Isamu
    Watanabe, Takashi
    Oe, Yasuhiro
    Kodama, Yoshitoshi
    Aoki, Kenta
    Suwa, Katsunori
    Fukuda, Sumiaki
    Yata, Shinji
    Inaba, Takashi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (07) : 1228 - 1233
  • [34] A Role for GPR119 in Lipid and Lipoprotein Metabolism
    Brown, Kathleen K.
    Bergquist, Mandy L.
    Shadoan, Melanie K.
    Carpenter, Andrew J.
    Young, Andrew A.
    Feldman, Paul L.
    Nunez, Derek J.
    Van den Hoek, Anita
    Princen, Hans M.
    [J]. DIABETES, 2012, 61 : A160 - A160
  • [35] Design of potent and selective GPR119 agonists for type II diabetes
    Szewczyk, Jason W.
    Acton, John
    Adams, Alan D.
    Chicchi, Gary
    Freeman, Stanley
    Howard, Andrew D.
    Huang, Yong
    Li, Cai
    Meinke, Peter T.
    Mosely, Ralph
    Murphy, Elizabeth
    Samuel, Rachel
    Santini, Conrad
    Yang, Meng
    Zhang, Yong
    Zhao, Kake
    Wood, Harold B.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2665 - 2669
  • [36] Optimization of a novel series of potent and orally bioavailable GPR119 agonists
    Koshizawa, Tomoaki
    Morimoto, Toshiharu
    Watanabe, Gen
    Watanabe, Toshiaki
    Yamasaki, Nao
    Sawada, Yoshikazu
    Fukuda, Tomoaki
    Okuda, Ayumu
    Shibuya, Kimiyuki
    Ohgiya, Tadaaki
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3249 - 3253
  • [37] Synthesis and evaluation of novel fused pyrimidine derivatives as GPR119 agonists
    Fang, Yuanying
    Xiong, Lijuan
    Hu, Jianguo
    Zhang, Shaokun
    Xie, Saisai
    Tu, Liangxing
    Wan, Yang
    Jin, Yi
    Li, Xiang
    Hu, Shaojie
    Yang, Zunhua
    [J]. BIOORGANIC CHEMISTRY, 2019, 86 : 103 - 111
  • [38] Synthesis and SAR studies of bicyclic amine series GPR119 agonists
    Sakairi, Masao
    Kogami, Masakazu
    Torii, Masafumi
    Kataoka, Hiroyo
    Fujieda, Hiroki
    Makino, Mitsuhiro
    Kataoka, Daisuke
    Okamoto, Ryuji
    Miyazawa, Toshiyuki
    Okabe, Morio
    Inoue, Megumi
    Takahashi, Naoki
    Harada, Satoko
    Watanabe, Nobuhide
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 5123 - 5128
  • [39] Discovery of structurally novel, potent and orally efficacious GPR119 agonists
    Alper, Phil
    Azimioara, Mihai
    Cow, Christopher
    Mutnick, Daniel
    Nikulin, Victor
    Michellys, Pierre-Yves
    Wang, Zhiliang
    Reding, Esther
    Paliotti, Michael
    Li, Jing
    Bao, Dingjiu
    Zoll, Jocelyn
    Kim, Young
    Zimmerman, Matthew
    Groessel, Todd
    Tuntland, Tove
    Joseph, Sean B.
    McNamara, Peter
    Seidel, H. Martin
    Epple, Robert
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (10) : 2383 - 2387
  • [40] Targeting GPR119 for the Potential Treatment of Type 2 Diabetes Mellitus
    Mo, Xiu-Lei
    Yang, Zhao
    Tao, Ya-Xiong
    [J]. GLUCOSE HOMEOSTATIS AND THE PATHOGENESIS OF DIABETES MELLITUS, 2014, 121 : 95 - 131
12345